---
title: "Aligos Therapeutics to report Q2 2026 financial results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294361458.md"
description: "Aligos Therapeutics will report its second-quarter 2026 financial results on August 6, 2026, prior to the U.S. market open."
datetime: "2026-07-30T12:03:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294361458.md)
  - [en](https://longbridge.com/en/news/294361458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294361458.md)
---

# Aligos Therapeutics to report Q2 2026 financial results

-   Aligos Therapeutics will report second-quarter 2026 financial results on Aug. 6, 2026, before the U.S. market open. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md)

## Related News & Research

- [Aligos Q2 FY26 net loss narrows 91% to $1.5 million](https://longbridge.com/en/news/295103944.md)
- [VGP to host webcast on H1 2026 results](https://longbridge.com/en/news/295056101.md)
- [Mobilezone schedules investor video conference on H1 2026 results](https://longbridge.com/en/news/294935560.md)
- [Marcopolo attends APIMEC 2026 investor meeting](https://longbridge.com/en/news/294988798.md)
- [Grupo Clarin schedules webcast to discuss second-quarter 2026 results](https://longbridge.com/en/news/294738587.md)